Adjuvant and neoadjuvant therapy with cyclin-dependent kinase 4 and 6 inhibitors in hormone receptor-positive, human epidermal growth factor receptor 2-negative early breast cancer: a systematic review and meta-analysis.

Zhang, Meilin; Song, Jian; Guo, Shigang; Jin, Feng; Zheng, Ang

Zhang, Meilin; Song, Jian; Guo, Shigang; Jin, Feng; Zheng, Ang.

Afiliación

Zhang M; Department of Burn and Plastic Surgery, Chaoyang Central Hospital, Chaoyang, Liaoning Province, China.
Song J; Department of Breast Surgery, the First Hospital of China Medical University, Shenyang, Liaoning Province, China.
Guo S; Department of General Surgery, Chaoyang Central Hospital, Chaoyang, Liaoning Province, China.
Jin F; Department of Breast Surgery, the First Hospital of China Medical University, Shenyang, Liaoning Province, China.
Zheng A; Department of Breast Surgery, the First Hospital of China Medical University, Shenyang, Liaoning Province, China.

Endocr Relat Cancer ; 30(8)2023 08 01.

Article en En | MEDLINE | ID: mdl-37283514

Asunto(s)

Neoplasias de la Mama; Terapia Neoadyuvante; Femenino; Humanos; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico; Neoplasias de la Mama/patología; Quinasa 4 Dependiente de la Ciclina/antagonistas & inhibidores; Recurrencia Local de Neoplasia; Receptor ErbB-2/metabolismo; Inhibidores de Proteínas Quinasas/uso terapéutico

Palabras clave

CDK4/6 inhibitors; early breast cancer; endocrine therapy; randomized controlled trial

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Terapia Neoadyuvante Tipo de estudio: Clinical_trials / Prognostic_studies / Systematic_reviews Límite: Female / Humans Idioma: En Revista: Endocr Relat Cancer Asunto de la revista: ENDOCRINOLOGIA / NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google